We partner with the media to inform the public of the global human crisis.
Updates on the Department of Justice Action
Get updates and information on Indivior’s ongoing response to the recent action by the U.S. Department of Justice and learn about the company’s unwavering commitment to patients, doctors, and communities fighting opioid addiction.
See more >
May 16, 2019Indivior to present at Jeffries 2019 Healthcare Conference...
May 9, 2019Indivior Enters into Exclusive License Agreement with HLS Therapeutics for PERSERIS™ (risperidone) in Canada...
May 8, 20192019 Annual General Meeting...
May 2, 2019Indivior PLC Q1 2019 Financial Results...
April 9, 2019Company Believes U.S. Justice Department Is Fundamentally Wrong, Will Contest Charges Vigorously...
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline